SEC Company Response from IRADIMED CORP (IRMD) (CIK 0001325618) (IRMD) — Sep 2, 2020
IRADIMED CORP (IRMD) (CIK 0001325618)
Date: Sept. 2, 2020 · CIK: 0001325618 · Accession: 0000898432-20-000757
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-248192
Letter
IRADIMED CORPORATION
1025 Willa Springs Drive
Winter Springs, FL 32708
VIA EDGAR
September 2, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, DC 20549
Attn:
Ms. Margaret Schwartz
Re:
Iradimed Corporation
Registration Statement on Form S-3
File No. 333-248192
Acceleration Request
Requested Date:
September 3, 2020
Requested Time:
4:30 p.m. Eastern Time (or as soon thereafter as practicable)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, IRADIMED CORPORATION, a Delaware corporation (the “Registrant”), hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on September 3, 2020 at 4:30 p.m. Eastern Time, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes K&L Gates LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to our counsel, K&L Gates LLP, by calling Ms. Jacqulyn Lewis at (949) 623-3568.
Sincerely,
IRADIMED CORPORATION
Show Raw Text
CORRESP
1
filename1.htm
IRADIMED CORPORATION
1025 Willa Springs Drive
Winter Springs, FL 32708
VIA EDGAR
September 2, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, DC 20549
Attn:
Ms. Margaret Schwartz
Re:
Iradimed Corporation
Registration Statement on Form S-3
File No. 333-248192
Acceleration Request
Requested Date:
September 3, 2020
Requested Time:
4:30 p.m. Eastern Time (or as soon thereafter as practicable)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, IRADIMED CORPORATION, a Delaware corporation (the “Registrant”), hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on
Form S-3 to become effective on September 3, 2020 at 4:30 p.m. Eastern Time, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant
hereby authorizes K&L Gates LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to our counsel, K&L Gates LLP, by calling
Ms. Jacqulyn Lewis at (949) 623-3568.
Sincerely,
IRADIMED CORPORATION
By:
/s/ Roger Susi
Roger Susi
President, Chief Executive Officer and Chairman
of the Board of Directors
cc:
Leib Orlanski, K&L Gates LLP
Jacqulyn L. Lewis, K&L Gates LLP